Aedes aegypti
Overview
Aedes aegypti is the primary mosquito vector for dengue virus transmission. It is an urban-adapted species that preferentially bites humans and breeds in small standing water containers. It is the principal vector across tropical and subtropical regions where dengue is endemic or epidemic.
Key Points from Literature
- Cited as the dengue transmission vector in Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism (background mention only; not a focus of the study).
- Cited as the primary vector in Lin2006 - Autoimmune Pathogenesis in Dengue Virus Infection and Lin2011 - Molecular Mimicry Virus Host Dengue Pathogenesis (background epidemiological context in both NCKU Taiwan reviews).
- Cited as vector background in Sungnak2025 - Distinct Immune Responses Asymptomatic Symptomatic Dengue (Thailand cohort context).
Vector biology (Guzman2016)
- Becomes infective after taking a blood meal from a viraemic patient during the viraemic window (24–48h before fever onset through ~day 5 of illness); viraemic persons — including asymptomatic individuals — can infect feeding mosquitoes (see Guzman2016 - Dengue Infection)
- Extrinsic incubation period: 5–12 days in the mosquito (blood meal to virus reaching salivary glands); generally 8–10 days; once infected, the mosquito remains infective for life
- Intrinsic incubation period (human infection to fever): 3–14 days (average 4–7 days)
- Urban-adapted; preferential human biter; breeds in small peridomestic water containers (vases, tyres, gutters); highly susceptible to indoor residual spraying and larval source reduction
Differential DENV-2 replication by genotype (Bhatt2020)
The Asian genotype of DENV-2 replicates more efficiently in Ae. aegypti salivary glands than the American DENV-2 genotype (see Bhatt2020 - Dengue Pathogenesis Review). Salivary gland replication efficiency is a key determinant of transmission potential — only virus that successfully disseminates from the midgut to the salivary glands can be transmitted to a new human host during a subsequent blood meal. This genotype-specific differential explains in part why the Southeast Asian DENV-2 genotype is epidemiologically more aggressive (higher transmission rate, higher epidemic potential) than the American genotype, even when other host and environmental factors are held constant.
Vector control programmes
- Cuba: insecticide spraying programme initiated 1981 after the DENV-2 epidemic; combined larval source reduction, adulticidal spraying, and community engagement (same three pillars as Singapore); epidemic dengue successfully controlled for ~30 years until the programme failed due to economic difficulties and re-introduction (see Guzman2016 - Dengue Infection)
- Singapore: year-round surveillance and control programme with statutory enforcement; sustained multi-decade dengue control despite high-density urban population (see Guzman2016 - Dengue Infection)
- Wolbachia (wMel): endosymbiotic bacterium suppresses DENV replication in Ae. aegypti and shortens mosquito lifespan; cytoplasmic incompatibility spreads wMel through mosquito populations without continuous releases; sustainable biological control approach (see Wolbachia)
- Sterile insect technique (SIT): releases of radiation-sterilised male Ae. aegypti to suppress wild female reproduction; field trials conducted in Asia and the Americas; requires sustained releases but leaves no genetic modification in the environment (see Guzman2016 - Dengue Infection)
Multi-arbovirus vector role and co-transmission (Farias2024)
Farias2024 - Dengue Mimickers (narrative review, Brazil) expands the vector context:
- Ae. aegypti transmits all four DENV serotypes, YFV, CHIKV, and ZIKV
- Both Ae. aegypti and Ae. albopictus, when co-infected with DENV and CHIKV, can replicate and disseminate both viruses independently
- Co-transmission in single bite documented — a mosquito co-infected with two arboviruses can transmit both simultaneously in a single bite; this is the mechanistic basis for observed clinical coinfections
- Ae. aegypti is theoretically incapable of co-infection with YFV when already carrying DENV (and vice versa), per a competition/exclusion hypothesis in some Asian countries — proposed as a mechanism limiting DEN-YFV coinfection despite geographic overlap
- Brazil co-circulates DENV, CHIKV, ZIKV, OROV, and MAYV — all transmitted by Ae. aegypti or closely related species, making co-infection a realistic differential diagnosis consideration during epidemics (narrative review — secondary source)
Contradictions & Debates
None yet recorded.
Related Pages
Sources
- Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism (background mention only)
- Lin2006 - Autoimmune Pathogenesis in Dengue Virus Infection (background mention)
- Lin2011 - Molecular Mimicry Virus Host Dengue Pathogenesis (background mention)
- Sungnak2025 - Distinct Immune Responses Asymptomatic Symptomatic Dengue (background mention)
- Guzman2016 - Dengue Infection (vector biology, incubation periods, control programme histories)
- Bhatt2020 - Dengue Pathogenesis Review (Asian genotype DENV-2 enhanced salivary gland replication in Ae. aegypti — underlying mechanism of genotypic virulence differential; review, India)
- Gawali2021 - ANA Prevalence in Seroconverted Dengue Patients (background mention as primary dengue vector; Gwalior, Central India context)
- Pang2017 - DHF Pathogenesis Review (background mention as primary dengue vector; review, China)
- Rajadhyaksha2012 - Dengue Evolving into SLE and Lupus Nephritis (background mention as primary dengue vector; Mumbai India; n=1 case report)
- Jardim2012 - Autoimmune Features DHF Case Report (implied primary dengue vector in Campinas São Paulo dengue-endemic area; DENV-3 outbreak May 2007 context; background mention; Brazil; n=1 case report)
- Farias2024 - Dengue Mimickers (multi-arbovirus vector context: Ae. aegypti transmits DENV/CHIKV/ZIKV/YFV; co-infection via single bite documented; DENV-YFV competitive exclusion hypothesis; Brazil narrative review)
- Hung2008 - Anti-Platelet Anti-Endothelial Autoantibodies Vietnam (background mention as primary dengue vector in hyperendemic Vietnam; HCMC 1998–2002; paediatric DHF/DSS cohort)